Your browser doesn't support javascript.
loading
Subsequent Cancers in Patients Affected with Moderate or Severe Chronic Graft-versus-Host Disease.
Schaar, Dana A; Pirsl, Filip; Holtzman, Noa; Steinberg, Seth M; Nashed, Jeannette; Ruben, Claire; Cowen, Edward W; Mays, Jacqueline W; Mitchell, Sandra; Ostojic, Alen; Munshi, Pashna N; Joe, Galen O; Comis, Leora E; Morton, Lindsay; Pavletic, Steven Z.
Afiliação
  • Schaar DA; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Pirsl F; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Holtzman N; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Steinberg SM; Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Nashed J; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Ruben C; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Cowen EW; Dematology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland.
  • Mays JW; Oral Immunobiology Unit, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland.
  • Mitchell S; Outcomes Research Branch, Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Ostojic A; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Division of Hematology, Department of Internal Medicine, University Hospital Center Zagreb, Zagreb, Croatia.
  • Munshi PN; MedStar Georgetown University Hospital, Washington, District of Columbia.
  • Joe GO; Department of Rehabilitation Medicine, National Institutes of Health Clinical Center, Bethesda, Maryland.
  • Comis LE; Department of Rehabilitation Medicine, National Institutes of Health Clinical Center, Bethesda, Maryland.
  • Morton L; Division of Cancer Epidemiology and Genetics, Radiation Epidemiology Branch, National Cancer Institute, National Institutes of Health, Rockville, Maryland.
  • Pavletic SZ; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Electronic address: pavletis@mail.nih.gov.
Transplant Cell Ther ; 27(11): 937.e1-937.e7, 2021 11.
Article em En | MEDLINE | ID: mdl-34380090
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Basocelular / Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Basocelular / Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article